OverviewChartNewsTraderScreen

180 Life Sciences Corp/  US68236V3024  /

IEX
2024-05-24  9:49:15 PM Chg. -0.04 Volume Bid- Ask- High Low
1.62USD -2.12% 625
Turnover: 1,082.19		 -Bid Size: - -Ask Size: - 1.78 1.62
GlobeNewswire 03-14 180 Life Sciences Regains Full Compliance with Nasdaq Minimum Bid Price Requirement
GlobeNewswire 02-26 180 Life Sciences Corp. Announces 1-For 19 Reverse Stock Split as Part of Nasdaq Compliance Plan
GlobeNewswire 2023-12-04 180 Life Sciences Engages Financial Advisor to Explore Strategic Alternatives
GlobeNewswire 2023-11-30 Capstone Technologies Appoints Frank Knuettel to Board of Directors
GlobeNewswire 2023-11-28 180 Life Sciences Announces Review of Strategic Alternatives
GlobeNewswire 2022-02-17 180 Life Sciences Corp. Forms Scientific Advisory Board
GlobeNewswire 2022-01-31 180 Life Sciences Corp. CEO James Woody, MD, PhD Issues Letter to Shareholders
GlobeNewswire 2021-12-28 180 Life Sciences Corp. To Participate in the Biotech Showcase 2022 Virtual Conference To be Held Ja...
GlobeNewswire 2021-12-15 180 Life Sciences Corp. Enters into a License Agreement with University of Oxford for Regenerative M...
GlobeNewswire 2021-12-06 180 Life Sciences Provides Follow-Up Information on Oxford University and the Company’s Successful D...
GlobeNewswire 2021-12-01 180 Life Sciences Corp. Co-Founder Prof. Jagdeep Nanchahal Presents Keynote Address at the 2021 Inte...
GlobeNewswire 2021-11-22 180 Life Sciences Corp. Expands Patent Portfolio
GlobeNewswire 2021-11-18 180 Life Sciences Corp. Co-Founder Prof. Jagdeep Nanchahal to Present a Keynote Address at the 2021 ...
GlobeNewswire 2021-11-03 180 Life Sciences Corp. Names Quan A. Vu Chief Operating Officer/Chief Business Officer
GlobeNewswire 2021-10-26 180 Life Sciences Corp. Publishes Pre-Clinical Study Report on the Effects of CBG Derivatives on Pai...
GlobeNewswire 2021-09-30 180 Life Sciences Corp. Continues To Expand Intellectual Property Portfolio
GlobeNewswire 2021-09-20 Celltrion Healthcare and 180 Life Sciences Enter Into Memorandum of Understanding for a Supply Agree...
GlobeNewswire 2021-08-30 180 Life Sciences Corp. CEO James Woody, MD, PhD Issues Letter to Stockholders
GlobeNewswire 2021-08-24 180 Life Sciences Corp. Announces Closing of $15.0 Million Private Placement
GlobeNewswire 2021-08-19 180 Life Sciences Corp. Announces $15.0 Million Private Placement
GlobeNewswire 2021-08-02 Chairman of the 180 Life Sciences Clinical Advisory Board, Professor Jagdeep Nanchahal, has Been Inv...
GlobeNewswire 2021-07-29 180 Life Sciences to Participate in Fireside Chat at BTIG Virtual Biotechnology Conference
GlobeNewswire 2021-07-28 180 Life Sciences Announces Selection of Lead Synthetic CBD Analogue
GlobeNewswire 2021-07-20 180 Life Sciences Regains Nasdaq Compliance Under Listing Rule 5250(c)(1)
GlobeNewswire 2021-07-12 180 Life Sciences Regains Nasdaq Compliance for Listing Rules 5605(b)(1) and 5605(c)(2)